CLEVELAND and DENMARK, August 5, 2024 -- In a new initiative that blends innovation in quantum technologies and artificial intelligence (AI) with clinical applications, the Novo Nordisk Foundation (NNF), together with Cleveland Clinic, has launched the Cleveland Clinic – Denmark: Quantum-AI Biomedical Frontiers Fellowship Program.

This program, crafted jointly by the Denmark-based NNF and Cleveland Clinic, is dedicated to integrating quantum technologies and AI into biomedical research and patient care, propelling the application of these technologies in medical science and healthcare.

"The collaboration between NNF and Cleveland Clinic is designed to enable the use of advanced critical technologies, such as quantum technology and AI, in biomedical research and practical clinical applications, ensuring these innovative technologies contribute to the understanding of disease and improving patient outcomes," said Lene Oddershede, Senior Vice President, Head of Natural and Technical at Novo Nordisk Foundation.

"This fellowship is a testament to the power of collaboration between Cleveland Clinic and the Novo Nordisk Foundation,” said Lara Jehi, MD, Chief Research Information Officer, Cleveland Clinic. “By combining our strengths, we aim to accelerate the translation of quantum technologies and artificial intelligence into clinical settings, fostering a new era of medical innovation that draws on the best of both our institutions. Our vision is to develop the biomedical researchers of tomorrow, those who can harness data and technology to benefit science and our patients."

NNF will grant up to DKK 43 million ($6.2 million USD) over the next three years to support exchange of 12 researchers, providing them each with a three-year term to conduct high-level research either at Cleveland Clinic or in Denmark. In Cleveland, the fellows will also have the opportunity to work with IBM researchers collaborating with Cleveland Clinic scientists through the Discovery Accelerator partnership.

The program leverages quantum technologies and AI around key scientific areas, including:

Enhanced diagnostic precision: Utilizing quantum sensing and AI-driven analytics to improve diagnostics, thereby increasing accuracy and reducing diagnostic times.

Innovative drug discovery: Applying quantum computing and machine learning algorithms to simulate and predict molecular interactions at an unprecedented scale and speed, potentially reducing the time and cost associated with discovering new drugs.

Optimization of clinical trials: Employing sophisticated data analysis tools to improve the design and efficiency of clinical trials, enabling more personalized medicine approaches.

Personalized medicine development: Using AI to analyze vast datasets from genomic information and clinical records to tailor treatments to individual patients.

In addition to a focus on academic research, this program also encourages applicants to consider industrial placements lasting three to six months with leading technology companies and startups. These placements are intended to provide practical experience and foster the translation of research innovations into market-ready medical solutions.